BMSSC
EW icon

B. Metzler seel. Sohn & Co’s Edwards Lifesciences EW Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Sell
41,753
-14,264
-25% -$1.19M 0.03% 287
2026
Q1 		$4.49M Buy
56,017
+737
+1% +$60.8K 0.04% 237
2025
Q4 		$4.72M Buy
55,280
+135
+0.2% +$11.1K 0.04% 231
2025
Q3 		$4.29M Hold
55,145
– – 0.04% 228
2025
Q2 		$4.31M Sell
55,145
-10,962
-17% -$818K 0.04% 215
2025
Q1 		$4.79M Buy
66,107
+2,461
+4% +$176K 0.05% 184
2024
Q4 		$4.71M Sell
63,646
-16,712
-21% -$1.17M 0.05% 183
2024
Q3 		$5.3M Sell
80,358
-7,803
-9% -$567K 0.05% 185
2024
Q2 		$8.14M Buy
88,161
+9,161
+12% +$811K 0.08% 120
2024
Q1 		$7.47M Buy
79,000
+11,678
+17% +$981K 0.08% 127
2023
Q4 		$5.13M Buy
67,322
+7,724
+13% +$537K 0.07% 176
2023
Q3 		$4.13M Sell
59,598
-52,569
-47% -$4.22M 0.06% 189
2023
Q2 		$10.6M Buy
112,167
+61,293
+120% +$5.33M 0.14% 97
2023
Q1 		$4.21M Hold
50,874
– – 0.07% 179
2022
Q4 		$3.8M Sell
50,874
-33,204
-39% -$2.56M 0.06% 191
2022
Q3 		$6.95M Sell
84,078
-1,883
-2% -$181K 0.13% 117
2022
Q2 		$8.17M Buy
85,961
+10,260
+14% +$1.06M 0.13% 112
2022
Q1 		$8.91M Sell
75,701
-3,196
-4% -$359K 0.12% 124
2021
Q4 		$10.3M Buy
78,897
+13,522
+21% +$1.58M 0.13% 107
2021
Q3 		$7.4M Sell
65,375
-938
-1% -$107K 0.11% 119
2021
Q2 		$6.87M Buy
66,313
+960
+1% +$90.5K 0.1% 127
2021
Q1 		$5.47M Buy
65,353
+6,345
+11% +$536K 0.09% 143
2020
Q4 		$5.51M Buy
+59,008
New +$4.89M 0.1% 125

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

B. Metzler seel. Sohn & Co's EW Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co reduced its Edwards Lifesciences (EW) stake by 25% in Q2 2026, selling an estimated $1.19M and leaving 41,753 shares worth $3.78M. The position accounts for 0.03% of the portfolio, ranked #287.

B. Metzler seel. Sohn & Co first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.6M in Q2 2023. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 41,753 shares of Edwards Lifesciences worth $3.78M as of Q2 2026.
  • B. Metzler seel. Sohn & Co sold 14,264 Edwards Lifesciences shares in Q2 2026, an estimated $1.19M.
  • Edwards Lifesciences made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #287 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Edwards Lifesciences position peaked at $10.6M in Q2 2023.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.